213
Views
5
CrossRef citations to date
0
Altmetric
Case report

Molybdenum Cofactor Deficiency: Mega Cisterna Magna in Two Consecutive Pregnancies and Review of the Literature

, ORCID Icon, , , &
Pages 49-55 | Published online: 30 Jan 2020

References

  • Reiss J, Hahnewald R. Molybdenum cofactor deficiency: mutations in GPHN, MOCS1 and MOCS2. Hum Mutat. 2011;32(1):10–18. doi:10.1002/humu.21390
  • Orphanet [homepage on the Internet]. Encephalopathy due to sulfite oxidase deficiency; 2012. Available from: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Ing=ES&Expert=833. Accessed May 10, 2019.
  • Durmaz MS, Özbakir B. Molybdenum cofactor deficiency: neuroimaging findings. Radiol Case Rep. 2018;13(3):592–595. doi:10.1016/j.radcr.2018.02.025
  • Higuchi R, Sugimoto T, Tamura A, et al. Early features in neuroimaging of two siblings with molybdenum cofactor deficiency. Pediatrics. 2014;133(1):e267–e271. doi:10.1542/peds.2013-0935
  • Omim [homepage on the Internet]. Molybdenum cofactor deficiency, complementation group A, MOCODA; 2013. Available from: http://www.omim.org/entry/252150. Accessed January 1, 2016.
  • Palacios A, García MT, Sánchez J, Nogales A, Puche A, Ugarte M. Déficit del cofactor Molibdeno como causa de encefalopatía epiléptica precoz [Molybdenum cofactor deficiency as a cause of early epileptic encephalopathy]. An Pediatr. 2008;69(2):187–189. doi:10.1157/13124906
  • Claerhout H, Witters P, Régal L, et al. Isolated sulfite oxidase deficiency. J Inherit Metab Dis. 2018;41(1):101–108. doi:10.1007/s10545-017-0089-4
  • Hitzert MM, Bos AF, Bergman KA, et al. Favorable outcome in a newborn with molybdenum cofactor type A deficiency treated with cPMP. Pediatrics. 2012;130(4):e1005–e1010. doi:10.1542/peds.2011-3330
  • Belaidi AA, Arjune S, Santamaria-Araujo JA, Sass JO, Schwarz G. Molybdenum cofactor deficiency: a new HPLC method for fast quantification of S-Sulfocysteine in urine and serum. JIMD Rep. 2012;5:35–43.
  • Mendel RR. The molybdenum cofactor. J Biol Chem. 2013;288:13165–13172. doi:10.1074/jbc.R113.455311
  • Reiss J, Gross-Hardt S, Christensen E, Schmidt P, Mendel RR, Schwarz G. A mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency. Am J Hum Genet. 2001;68(1):208–213. doi:10.1086/316941
  • Mayr SJ, Sass JO, Vry J, et al. A mild case of molybdenum cofactor deficiency defines an alternative route of MOCS1 protein maturation. J Inherit Metab Dis. 2018;41(2):187–196. doi:10.1007/s10545-018-0138-7
  • Huijmans JGM, Schot R, Klerk JBC, et al. Molybdenum cofactor deficiency: identification of a patient with homozygote mutation in the MOCS3 gene. Am J Med Genet. 2017;173(6):1601–1606. doi:10.1002/ajmg.a.38240
  • Scelsa B, Gasperini S, Righini A, et al. Mild phenotype in Molybdenum cofactor deficiency: a new patient and review of the literature. Mol Genet Genomic Med. 2019;7(6):e657. doi:10.1002/mgg3.657
  • Carmi-Nawi N, Malinger G, Mandel H, Ichida K, Lerman-Sagie T, Lev D. Prenatal brain disruption in molybdenum cofactor deficiency. J Child Neurol. 2011;26(4):460–464. doi:10.1177/0883073810383017
  • Lubout CMA, Derks TGJ, Meiners L, et al. Molybdenum cofactor deficiency type A: prenatal monitoring using MRI. Eur J Paediatr Neurol. 2018;22(3):536–540. doi:10.1016/j.ejpn.2017.11.006
  • Vijayakumar K, Gunny R, Grunewald S, et al. Clinical neuroimaging features and outcome in molybdenum cofactor deficiency. Pediatr Neurol. 2011;45(4):246–252. doi:10.1016/j.pediatrneurol.2011.06.006
  • GeneReviews® [homepage on the Internet]. Hereditary Hyperekplexia. Seattle (WA): University of Washington; 2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1260/. Accessed December 19, 2019.
  • Reid Sutton V. Inborn errors of metabolism: classification. UpToDate. 2019. Available from: https://www.uptodate.com/contents/inborn-errors-of-metabolism-classification#H15. Accessed 22 January 2020.
  • Kumar A, Dejanovic B, Hetsch F, et al. S-sulfocysteine/NMDA receptor-dependent signaling underlies neurodegeneration in molybdenum cofactor deficiency. J Clin Invest. 2017;127(12):4365–4378. doi:10.1172/JCI89885